Frameshift Variant in ARID2 in a Chilean Individual with Coffin–Siris Syndrome Phenotype

Abstract

Coffin–Siris syndrome (CSS) is one of the several causes of intellectual disability (ID) and, since its first description, has posed diagnostic challenges given its variability and phenotypic overlap with other alterations of chromatin-remodeling-associated syndromes. It is genetically heterogeneous, and causative mutations are detected in less than 70% of cases. The different subtypes of the syndrome described to date are caused by mutations in genes that encode subunits of the SWI/SNF chromatin-remodeling complex, which plays an essential role in the regulation of gene expression during embryogenesis. Whole exome sequencing (WES) has allowed the identification of pathogenic mutations in these genes, including ARID2. ARID2 is one of the primary components of the SWI/SNF complex and has been associated with ID and phenotypes similar to CSS for the first time in 2015. Fifteen published case reports have identified loss-of-function mutations, suggesting that the underlying pathogenic disease mechanism is haploinsufficiency of ARID2.

We herein presented the case of an 8-year-old Chilean girl with clinical suspicion of CSS, in whom a novel frameshift variant in ARID2 was identified by WES. She was the first reported case in Latin America to our knowledge and her phenotype displays the main clinical features suggestive of CSS described in other patients with ARID2 variants. However, she did not present behavioral abnormalities, a characteristic frequently reported in the majority of patients with ARID2 variants, and also had some features, such as sparse scalp hair, which is frequently reported as a manifestation of CSS, but is uncommon in this new group of patients.

Keywords

ARID2 - Coffin–Siris - intellectual disability - neurodevelopmental disorders - whole exome sequencing

Authors' Contributions

All authors contributed to the clinical diagnosis process, literature review, and manuscript redaction and review.

Publication History

Received: 16 March 2021

Accepted: 31 October 2021

Article published online:
24 December 2021

• References

• 1 Coffin GS, Siris E. Mental retardation with absent fifth fingernail and terminal phalanx. Am J Dis Child 1970; 119 (05) 433-439
• 2 Mannino EA, Miyawaki H, Santen G, Schrier Vergano SA. First data from a parent-reported registry of 81 individuals with Coffin-Siris syndrome: natural history and management recommendations. Am J Med Genet A 2018; 176 (11) 2250-2258
• 3 Sekiguchi F, Tsurusaki Y, Okamoto N. et al. Genetic abnormalities in a large cohort of Coffin-Siris syndrome patients. J Hum Genet 2019; 64 (12) 1173-1186
• 4 Chandler RL, Magnuson T. The SWI/SNF BAF-A complex is essential for neural crest development. Dev Biol 2016; 411 (01) 15-24
• 5 Santen GWE, Aten E, Vulto-van Silfhout AT. et al; Coffin-Siris consortium. Coffin-Siris syndrome and the BAF complex: genotype-phenotype study in 63 patients. Hum Mutat 2013; 34 (11) 1519-1528
• 6 Gazdagh G, Blyth M, Scurr I. et al; DDD Study. Extending the clinical and genetic spectrum of ARID2 related intellectual disability. A case series of 7 patients. Eur J Med Genet 2019; 62 (01) 27-34
• 7 Bramswig NC, Caluseriu O, Lüdecke HJ. et al. Heterozygosity for ARID2 loss-of-function mutations in individuals with a Coffin-Siris syndrome-like phenotype. Hum Genet 2017; 136 (03) 297-305
• 8 Shang L, Cho MT, Retterer K. et al. Mutations in ARID2 are associated with intellectual disabilities. Neurogenetics 2015; 16 (04) 307-314
• 9 Van Paemel R, De Bruyne P, van der Straaten S. et al. Confirmation of an ARID2 defect in SWI/SNF-related intellectual disability. Am J Med Genet A 2017; 173 (11) 3104-3108
• 10 Khazanchi R, Ronspies CA, Smith SC, Starr LJ. Patient with anomalous skin pigmentation expands the phenotype of ARID2 loss-of-function disorder, a SWI/SNF-related intellectual disability. Am J Med Genet A 2019; 179 (05) 808-812
• 11 Tsurusaki Y, Okamoto N, Ohashi H. et al. Coffin-Siris syndrome is a SWI/SNF complex disorder. Clin Genet 2014; 85 (06) 548-554
• 12 Srivastava S, Love-Nichols JA, Dies KA. et al; NDD Exome Scoping Review Work Group. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med 2019; 21 (11) 2413-2421
• 13 Bögershausen N, Wollnik B. Mutational landscapes and phenotypic spectrum of SWI/SNF-related intellectual disability disorders. Front Mol Neurosci 2018; 11 (August): 252 DOI: 10.3389/fnmol.2018.00252.
• 14 Bostwick BL, McLean S, Posey JE. et al; Members of the Undiagnosed Diseases Network. Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders. Genome Med 2017; 9 (01) 73 DOI: 10.1186/s13073-017-0463-8.